Literature DB >> 3737868

The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection.

N J Ali, M Sillis, B E Andrews, P F Jenkins, B D Harrison.   

Abstract

The clinical, radiographic and microbiological data of 47 patients with Mycoplasma pneumoniae infection admitted to three Norfolk hospitals during a 20-month period between 1982 and 1983 have been reviewed. Thirty-nine presented with pneumonia and eight with non-pulmonary infection. The M. pneumoniae specific IgM test was positive in 42 of 45 patients tested (89 per cent); in 39 the levels were diagnostic on admission. Cold agglutinins were detected in 27 (57 per cent) and a fourfold rise in complement fixation titre was demonstrated in 13 (29 per cent). Sputum culture was positive in 12 (26 per cent). The extrapulmonary manifestations observed were haemolytic anaemia (17 per cent), Stevens Johnson syndrome (4.1 per cent), neurological abnormalities (4.1 per cent), arthritis (2.1 per cent), hepatitis (2.1 per cent) and pericarditis (2.1 per cent). One patient with multilobe pneumonia, pericardial effusion and haemolytic anaemia died. Six patients presented with a history of illness longer than a month; in three the clinical and radiographic picture suggested chronic disease (pulmonary tuberculosis, lymphoma and unresolving pneumonia). There were no distinctive clinical or radiographic features of M. pneumoniae infection. Diagnosis, therefore, relies on serological tests of which the most useful is the rapid, specific IgM test, positive in 86 per cent of the admission sera.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3737868

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  20 in total

1.  Antiphospholipid antibodies and Mycoplasma pneumoniae infection.

Authors:  N Snowden; P B Wilson; M Longson; R S Pumphrey
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

2.  The clinical diagnosis of Mycoplasma pneumoniae: the diagnostic importance of highly elevated serum cold agglutinins.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-01       Impact factor: 3.267

3.  Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence.

Authors:  C E Barker; M Sillis; T G Wreghitt
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

4.  Mycoplasma pneumoniae pneumonia: CT features in 16 patients.

Authors:  Inho Lee; Tae Sung Kim; Hye-Kyung Yoon
Journal:  Eur Radiol       Date:  2005-10-08       Impact factor: 5.315

5.  More on Mycoplasma pneumoniae pneumonia.

Authors:  L Dubins
Journal:  West J Med       Date:  1995-08

6.  Quality of published reports of the prognosis of community-acquired pneumonia.

Authors:  C A Carson; M J Fine; M A Smith; L A Weissfeld; J T Huber; W N Kapoor
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

Review 7.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Ιnflammatory or septic arthritis associated with mycoplasma pneumonia in children: Two case reports and review of the literature.

Authors:  Maria Vlachou; Prokopia Dialyna; Christos Bartsocas; Dimitris Dimitriadis
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-10-21

9.  Community acquired pneumonia: aetiology and prognostic index evaluation.

Authors:  N C Karalus; R T Cursons; R A Leng; C B Mahood; R P Rothwell; B Hancock; S Cepulis; M Wawatai; L Coleman
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

10.  Mycoplasma pneumoniae infection and neurological disease.

Authors:  N H Thomas; J E Collins; S A Robb; R O Robinson
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.